A Study to Evaluate the Efficacy and Safety of Mavacamten in Chinese Adults With Symptomatic Obstructive HCM
Study sponsor: LianBio LLC
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-03-06Actual
Enrollment · participants81Actual
Source updated2024-09-19Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.